Strongbridge Biopharma plc
SBBPDelisted Oct 5, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634432
Strongbridge Biopharma plc was delisted on Oct 5, 2021; its insiders filed their last Form 4 on Jan 5, 2022; 49 institutions reported holding it in 13F filings for Q3 2021, worth $69.8M in total; Fairfax Financial was the only superinvestor holding it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 49
- Q3 2021, −10 vs. previous quarter
- 13F value
- $69.8M
- Reported value at the end of Q3 2021
- Superinvestors holding
- 1
- At the end of Q3 2021
Superinvestors holding SBBP, Q3 2021
1 superinvestor reports holding Strongbridge Biopharma plc on Form 13F. Percentages are the stock's share of each portfolio.
Fairfax Financial
Prem Watsa
<0.1%
Strongbridge Biopharma plc's share of the portfolio
- Shares
- 193,107
- Value
- $392.0K
Latest insider trades
Open-market purchases and sales by Strongbridge Biopharma plc insiders from Form 4, newest first.
No open-market purchases or sales by Strongbridge Biopharma plc insiders are on file.
Top 10 13F holders, Q3 2021
The largest institutional positions in Strongbridge Biopharma plc at the end of Q3 2021; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caxton Corp | 8,024,542 | $16.4M | 13.27% | −58,900−0.7% | Reduced |
| Stonepine Capital Management, LLC | 4,489,687 | $9.16M | 4.17% | +1,184,070+35.8% | Added |
| NEA Management Company, LLC | 4,141,308 | $8.45M | 0.11% | 00.0% | Unchanged |
| Rubric Capital Management LP | 3,072,732 | $6.27M | 0.36% | +376,968+14.0% | Added |
| Vanguard Group Inc | 2,200,172 | $4.49M | 0.00% | 00.0% | Unchanged |
| Man Group plc | 1,966,636 | $4.01M | 0.01% | +983,318+100.0% | Added |
| Morgan Stanley | 1,774,307 | $3.62M | 0.00% | −183,044−9.4% | Reduced |
| Tudor Investment Corp Et Al | 1,529,426 | $3.12M | 0.06% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,371,400 | $2.80M | 0.00% | −56,500−4.0% | Reduced |
| OrbiMed Advisors LLC | 794,675 | $1.62M | 0.02% | −949,994−54.5% | Reduced |